Literature DB >> 30737893

Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.

Alanna M Kongkriangkai1,2, Christopher King1, Lisa J Martin1,2, Emily Wakefield1, Carlos E Prada1,2, Geraldine Kelly-Mancuso1, Elizabeth K Schorry1,2.   

Abstract

Tumor growths, migraine headaches, and other health-related complications reported in patients with neurofibromatosis type 1 (NF1) are often associated with pain. Thus, this study sought to describe and quantify the pain experience in children and young adults with NF1. Surveys were administered to 49 participants (28 children and 21 adults), ages 8 through 40 years. The survey included the Numeric Rating Scale 11 (NRS11) to assess pain intensity and the Patient Reported Outcomes Measurement Information System (PROMIS) to assess pain interference. A supplemental survey was created to measure pain frequency, chronicity, quality, and location. Results suggest pain is not only present in 55% of the cohort, but that it can begin at early ages. Pain was chronic in 35% of participants, with 41% reporting the use of medication to manage pain symptoms. Common sources of pain included migraine headaches and NF-related tumors. Pain was described as having neuropathic features (i.e., burning, tingling, numbness, or itching), and was localized to the head, back, and extremities. Further, subsets of participants reported moderate-to-severe pain intensity, high frequency of pain, and interference of pain in daily activities. Continued investigation of the pain experience in a multisystem disorder, such as NF1, remains essential to providing guidance in the setting of complex pain management.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NF1; interference; neurofibromatosis; neuropathic pain; pain

Mesh:

Year:  2019        PMID: 30737893      PMCID: PMC6451830          DOI: 10.1002/ajmg.a.61069

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

Review 1.  Clinical manifestations and management of neurofibromatosis type 1.

Authors:  James H Tonsgard
Journal:  Semin Pediatr Neurol       Date:  2006-03       Impact factor: 1.636

2.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

Authors:  S M Huson; D A Compston; P Clark; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

3.  Neurological complications of neurofibromatosis type 1 in adulthood.

Authors:  A Créange; J Zeller; S Rostaing-Rigattieri; P Brugières; J D Degos; J Revuz; P Wolkenstein
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

4.  Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.

Authors:  Carlton Dampier; Vaughn Barry; Heather E Gross; Yang Lui; Courtney D Thornburg; Darren A DeWalt; Bryce B Reeve
Journal:  Pediatr Blood Cancer       Date:  2016-02-19       Impact factor: 3.167

5.  Headache in patients with neurofibromatosis type 1.

Authors:  M Clementi; P A Battistella; L Rizzi; S Boni; R Tenconi
Journal:  Headache       Date:  1996-01       Impact factor: 5.887

6.  Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.

Authors:  Pamela L Wolters; Staci Martin; Vanessa L Merker; James H Tonsgard; Sondra E Solomon; Andrea Baldwin; Amanda L Bergner; Karin Walsh; Heather L Thompson; Kathy L Gardner; Cynthia M Hingtgen; Elizabeth Schorry; William N Dudley; Barbara Franklin
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

Review 7.  The biopsychosocial approach to chronic pain: scientific advances and future directions.

Authors:  Robert J Gatchel; Yuan Bo Peng; Madelon L Peters; Perry N Fuchs; Dennis C Turk
Journal:  Psychol Bull       Date:  2007-07       Impact factor: 17.737

8.  Social, emotional, and behavioral functioning of children with NF1.

Authors:  Robert B Noll; Jennifer Reiter-Purtill; Bartlett D Moore; Elizabeth K Schorry; Anne M Lovell; Kathryn Vannatta; Cynthia A Gerhardt
Journal:  Am J Med Genet A       Date:  2007-10-01       Impact factor: 2.802

Review 9.  Itch: scratching more than the surface.

Authors:  R Twycross; M W Greaves; H Handwerker; E A Jones; S E Libretto; J C Szepietowski; Z Zylicz
Journal:  QJM       Date:  2003-01

10.  A classification of chronic pain for ICD-11.

Authors:  Rolf-Detlef Treede; Winfried Rief; Antonia Barke; Qasim Aziz; Michael I Bennett; Rafael Benoliel; Milton Cohen; Stefan Evers; Nanna B Finnerup; Michael B First; Maria Adele Giamberardino; Stein Kaasa; Eva Kosek; Patricia Lavand'homme; Michael Nicholas; Serge Perrot; Joachim Scholz; Stephan Schug; Blair H Smith; Peter Svensson; Johan W S Vlaeyen; Shuu-Jiun Wang
Journal:  Pain       Date:  2015-06       Impact factor: 7.926

View more
  7 in total

1.  Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.

Authors:  James D Doorley; Jonathan Greenberg; Jafar Bakhshaie; Nathan S Fishbein; Ana-Maria Vranceanu
Journal:  J Neurooncol       Date:  2021-08-19       Impact factor: 4.506

2.  Treatment, Resource Use and Costs Among Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibromas.

Authors:  Xiaoqin Yang; Kaushal Desai; Neha Agrawal; Kirti Mirchandani; Sagnik Chatterjee; Eric Sarpong; Shuvayu Sen
Journal:  Pediatric Health Med Ther       Date:  2020-10-07

3.  Assessment of nociception and related quality-of-life measures in a porcine model of neurofibromatosis type 1.

Authors:  Rajesh Khanna; Aubin Moutal; Katherine A White; Aude Chefdeville; Pedro Negrao de Assis; Song Cai; Vicki J Swier; Shreya S Bellampalli; Marissa D Giunta; Benjamin W Darbro; Dawn E Quelle; Jessica C Sieren; Margaret R Wallace; Christopher S Rogers; David K Meyerholz; Jill M Weimer
Journal:  Pain       Date:  2019-11       Impact factor: 7.926

4.  Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report.

Authors:  Omar Hegazy; Howard Platnick
Journal:  Cureus       Date:  2019-12-06

Review 5.  The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.

Authors:  Amish Chinoy; Grace R Vassallo; Emma Burkitt Wright; Judith Eelloo; Siobhan West; Eileen Hupton; Paula Galloway; Amy Pilkington; Raja Padidela; M Zulf Mughal
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-03-01       Impact factor: 1.864

Review 6.  Neuropathic pain in children: Steps towards improved recognition and management.

Authors:  Suellen M Walker
Journal:  EBioMedicine       Date:  2020-11-25       Impact factor: 8.143

Review 7.  Neurofibromatosis in Children: Actually and Perspectives.

Authors:  Maria Lucia Sur; Ionel Armat; Genel Sur; Diana-Cristina Pop; Gabriel Samasca; Iulia Lupan; Teodora-Larisa Timis; Ioan-Alexandru Florian; Daniel Sur
Journal:  Children (Basel)       Date:  2022-01-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.